Agilon Health (NYSE:AGL) Shares Up 3.3% – Here’s Why

Agilon Health, Inc. (NYSE:AGL)’s share price rose 3.3% on Thursday . The stock traded as high as $97.26 and last traded at $96.6460. Approximately 26,568 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 341,372 shares. The stock had previously closed at $93.59.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on AGL shares. JPMorgan Chase & Co. raised their price objective on Agilon Health from $31.00 to $85.00 and gave the company an “underweight” rating in a research note on Monday, August 24th. Benchmark reissued a “buy” rating and issued a $140.00 target price (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Wells Fargo & Company restated an “overweight” rating and set a $146.00 target price (up from $141.00) on shares of Agilon Health in a report on Tuesday, August 11th. Citigroup upgraded Agilon Health from a “sell” rating to a “neutral” rating and raised their price target for the stock from $105.00 to $115.00 in a research report on Monday, August 10th. Finally, Robert W. Baird set a $116.00 price objective on Agilon Health in a research report on Thursday, August 6th. Five equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $97.70.

Agilon Health Price Performance

The stock has a market cap of $1.58 billion, a PE ratio of -6.59 and a beta of 3.02. The business’s 50-day simple moving average is $100.55 and its 200-day simple moving average is $68.36. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The company had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. On average, research analysts expect that Agilon Health, Inc. will post -2.11 EPS for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

Several hedge funds have recently made changes to their positions in AGL. LPL Financial LLC raised its holdings in Agilon Health by 213.4% in the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares in the last quarter. CIBC Bancorp USA Inc. purchased a new position in shares of Agilon Health during the third quarter valued at about $34,000. Focus Partners Advisor Solutions LLC purchased a new position in shares of Agilon Health during the fourth quarter valued at about $53,000. Alpine Global Management LLC bought a new position in Agilon Health in the fourth quarter worth about $84,000. Finally, Tower Research Capital LLC TRC raised its stake in Agilon Health by 214.0% in the second quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company’s stock worth $85,000 after buying an additional 25,270 shares in the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.